GANYMED PHARMACEUTICALS AG;JOHANNES GUTENBERG-UNIVERSITAET MAINZ, VERTRETEN DURCH DEN PRAESIDENTEN
发明人:
申请号：
EP06818817.6
公开号：
EP1948693B1
申请日:
2006.11.24
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder.
